Home
AavantiBio, Inc.

AavantiBio, Inc. Market Share Analysis for June 2026

aavantibio is changing the trajectory of precision genetic medicine. we believe it is possible to bring therapies to patients who live with genetic disorders.

Industry: N/A

Domainaavantibio.com

Year Founded2017

Employees51 - 200

Annual Revenue$5M - $10M

AavantiBio, Inc.

AavantiBio, Inc. (including company regionals)

aavantibio.com

See more website traffic and engagement information

AavantiBio, Inc. Revenue up to June 2026 is 5M - 10M

revenue generated by AavantiBio, Inc. top domains

AavantiBio, Inc. top domains revenue over 3 years

Revenue for AavantiBio, Inc. top domains

aavantibio.com5M - 10M

See more with Sales Intelligence

Total visits to AavantiBio, Inc.'s top domains

Understand AavantiBio, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in AavantiBio, Inc.'s top domains

Analyze AavantiBio, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on AavantiBio, Inc.'s top domains

See how AavantiBio, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

AavantiBio, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by AavantiBio, Inc.

These are the website technologies, by industry, used by AavantiBio, Inc. top domains

Widget (3)

Twemoji

Advertising (2)

PubMatic

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

8

See all

News & Signals from AavantiBio, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAavantibio hires Paul Herzich as Director of Quality.When Chief Technology Officer Paul Herzich and Director of Quality Faith Barnard joined AavantiBio, the company was in the process of evaluating electronic quality management systems (eQMS), but had not yet reached a decision.

NewsSolid Biosciences Inc. merged with Aavantibio on Jul 1st '22.Solid Biosciences Inc. (NASDAQ: SLDB)'s merger with AavantiBio, Inc.